Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Prostate Cancer|April 26, 2021
High Serum Alkaline Phosphatase Flare after First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted TherapySatoko Kojima, Hiroshi Masuda, Takahito Suyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 15, 2005
The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureterShuichi Kamijima, Toyofusa Tobe, Takahito Suyama, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 31, 2013
[Treatment outcome of intrarenal Bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract]Go Anan, Takahito Suyama, Nobuyoshi Takeuchi, et al.
Anticancer Research|September 3, 2021
Renal Function Improves After the Discontinuation of Androgen Deprivation Therapy in Japanese Patients With Prostate CancerHiroshi Masuda, Ayumi Fujimoto, Manato Kanesaka, et al.
In Vivo (Athens, Greece)|October 26, 2021
The Association Between Hot Flashes and Renal Dysfunction After Androgen Deprivation Therapy With Radiotherapy in Japanese Patients With High-risk Prostate CancerHiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 28, 2022
Outcomes of dutasteride discontinuation in patients with benign prostatic hypertrophyHiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Successful Response to Nivolumab Plus Ipilimumab Therapy in a Hemodialysis Patient With Metastatic Renal Cell CarcinomaHiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, et al.
In Vivo (Athens, Greece)|April 29, 2021
Validation of the Effectiveness of Neutrophil-to-lymphocyte Ratio (NLR) as a Predictive Factor in Patients Undergoing Prostate Biopsy With Prostate Specific Antigen (PSA) Between 4.0 and 10.0 ng/mlHiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 28, 2022
The choice of therapeutic agent in female overactive bladder patients in real-world practiceHiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 4, 2007
The efficacy and safety of laparoscopic nephrectomy in patients with three or more comorbiditiesYukio Naya, Toyofusa Tobe, Takahito Suyama, et al.
Pageof 4